MSI−/EBV− patients with FLI1 hypermethylation were associated with more liver metastasis than those without FLI1 hypermethylation, while no significant difference in initial recurrence patterns was observed in MSI+ or EBV+ patients (Table 3). This evidence concerns the gene FLI1 and metastasis.